Every week, FDA stops foreign food shipments that were otherwise destined for smooth entry into the United States with detentions and refusals. For many exporters, these holds feel unexpected—surprising even—but from FDA’s perspective, they are predictable outcomes of missing documentation, weak controls, or incomplete FSVP support.

What exporters experience as a “border problem” is almost always a pre-production problem that was never addressed. Detentions and refusals don’t happen because FDA is selective or unpredictable. They happen because the agency finds the same preventable issues repeated across foreign facilities worldwide.

Agitation matters here because the cost is not theoretical. Every day a shipment sits under review, the financial bleed intensifies: storage fees, demurrage, spoiled product, and importer frustration. This article clarifies why FDA stops shipments so consistently—and why the exporters who fix these issues early never see these problems again.

Missing or Incomplete FSVP Documentation

The most common issue behind delays is insufficient support for the Foreign Supplier Verification Program (FSVP). Importers must verify that foreign suppliers meet U.S. food safety standards, but exporters often fail to provide the documentation the importer is legally required to maintain.

These gaps appear when suppliers do not understand their role in FSVP requirements, leaving importers unable to produce the records FDA demands. When documentation is incomplete, the shipment is treated as high risk.

No Hazard Analysis or Inadequate Process Controls

FDA refuses shipments when exporters cannot demonstrate that hazards were identified and controlled. This often shows up as:

• No written hazard analysis
• Missing preventive control monitoring records
• Unsupported claims of process validation
• No documentation for allergen, microbial, or foreign material controls

These aren’t small clerical oversights. To FDA, they signify a system that cannot assure food safety. And when the system is questionable, the shipment halts immediately.

Labeling Issues That Signal Deeper Compliance Gaps

While exporters often worry most about labeling, FDA focuses on what labeling reveals. A misdeclared allergen, improper ingredient listing, or missing statement suggests that the underlying production controls may also be insufficient.

FDA does not detain a shipment because a label is imperfect—it detains it because the label signals a deeper documentation or process failure.

The Importer Cannot Shield You From Risk

Exporters frequently assume that the U.S. importer will absorb compliance responsibility. But the importer’s obligations under FSVP are verification obligations—not correction obligations.

When suppliers fail to support FSVP importer obligations, FDA views the shipment as noncompliant regardless of what the importer intended. Importers cannot:

• Fix a missing hazard analysis
• Recreate preventive control records
• Retroactively validate a supplier’s process
• Absorb FDA liability for a supplier’s weak systems

Facility Registration Problems

FDA detains shipments from foreign facilities that:

• Are not properly registered
• Have expired registrations
• Have discrepancies between facility data and shipment documentation

Registration errors do not only delay a shipment—they call into question the legitimacy of the exporter’s entire compliance status.

Repeated Failures Lead to Import Alerts

When FDA identifies recurring issues with a foreign supplier, the agency may place the facility, product, or manufacturer on Import Alert, allowing immediate detention of all future shipments without physical examination.

Import Alerts are not temporary inconveniences. They can halt market access for months or years and damage importer relationships beyond repair.

Why These Issues Keep Happening—And Why They’re Avoidable

None of the problems listed above require FDA intervention to prevent. Every one of them depends on the exporter’s own documentation, hazard controls, and process management.

The repeated pattern is this:

• Exporters assume compliance begins during shipping
• Importers assume suppliers understand U.S. requirements
• Brokers assume documentation provided is accurate
• FDA discovers the gaps only when the shipment arrives

By then, the financial and operational damage is already done.

Prevent the Problems Before FDA Has a Reason to Act

The exporters who avoid detentions, delays, and refusals are the ones who treat compliance as a production responsibility—not a last-minute shipment task. They know that meeting FDA expectations requires a defined system, not reactive corrections.

Registrar Corp’s Complete Compliance service equips foreign suppliers with the documentation, process controls, and FSVP alignment needed to ship confidently. Instead of hoping a shipment clears, you can build a system that makes delays unlikely.

To protect every shipment, reduce importer frustration, and avoid preventable enforcement, begin with FDA Compliance for Food Exports.